Since 2013, OPHTALMIS is dedicated to Research and Development in Ophthalmology. The company brings on the market new products to treat and prevent eye diseases : pharmaceutical products, medical devices, and dietary complements. We manage the development of product until regulatory approval (from formulation to approval of the MA dossier or Technical file by Authorities/Notified Body). Innovation is the cornerstone of OPHTALMIS strategy. For this purpose, we collaborate with researchers who are leaders in their field. Objectives for the coming years are to build and strengthen partnerships to develop innovative treatment and means of administration for eye care products. OPHTALMIS is working under an ISO13485:2016 certified Quality Management System. OPHTALMIS was founded by Martine Claret and Claude Claret, Pharmacists inspired by their knowledge of the Ophthalmology field and passion for Research and Development. Based in Monaco, OPHTALMIS is located at the heart of a dynamic region in terms of ophthalmology innovation. For any request, please contact us at the following email address : contact @ophtalmis.com